 An article in The West Australian has highlighted Orthocell’s rapid progress in securing 12 US distributors across 21 states for our flagship nerve repair product Remplirâ„¢.
Orthocell Receives Regulatory Approval for Remplirâ„¢ in Hong Kong
Orthocell has received regulatory approval from the Hong Kong Department of Health’s Medical Device Division to commence sales of Remplirâ„¢ in the Hong Kong nerve repair market.
Orthocell US Remplirâ„¢ Sales Rollout Gains Pace with 12 Distributors Now Appointed Covering 21 States
Orthocell has appointed 12 US distributors for its nerve repair product Remplirâ„¢, well ahead of the expected target of 10 distributors by 30 June.
Orthocell Secures Health Canada Approval for Remplirâ„¢ in US$75 million Canadian Market
Orthocell has secured a Medical Device Licence from Health Canada for Remplirâ„¢, opening access to the US$75 million Canadian nerve repair market.
Orthocell Receives Regulatory Approval to Commence Sales of Remplirâ„¢ in US$84 million Thai market
Orthocell has been granted a licence by the Food and Drug Administration of Thailand to commence sales of Remplirâ„¢ into the significant and growing US$84 million Thai nerve repair market.
Orthocell Appoints its First Four US Remplirâ„¢ Distributors
Orthocell has appointed four US distributors for its flagship nerve repair product Remplirâ„¢, enabling the commencement of commercial distribution into the US.
AusBiz | Interview with John Van Der Wielen
Orthocell Chair John Van Der Wielen spoke with Ausbiz about the Company’s ramp up in the US.
Orthocell Receives Regulatory Approval for Striate+ in Brazil
Orthocell has announced that Brazilian Health Regulatory Agency, ANVISA, has granted regulatory approval for the Company’s market-leading dental membrane, Striate+™, allowing the Company to commence sales in the large and important market of Brazil.
MEDIA | 7 News
Orthocell’s recent FDA clearance made headlines on 7 News this week, with journalist Alice Murray showcasing the human impact of our nerve repair technology.
MEDIA | 9 News
Orthocell welcomed 9 News journalist Michael Stamp to Orthocell HQ last week to film an in-depth segment about our FDA clearance for the nightly news.